Keyphrases
Cardiac Implantable Electronic Device Infection
100%
Atrial Fibrillation
100%
Cardiac Resynchronization Therapy
88%
Left Ventricular Lead
80%
Dialysis Patients
70%
Active Fixation
66%
End-stage Renal Disease
66%
Coronary Sinus Lead
66%
Lead Extraction
53%
Implantable Defibrillator
51%
Arrhythmia
51%
Tachycardia
50%
Cardiac Implantable Electronic Device
46%
Recurrent Ventricular Tachycardia
44%
United States Renal Data System (USRDS)
40%
Peritoneal Dialysis
40%
Hemodialysis
40%
Bleeding Risk Score
33%
Multi-user
33%
Clinical Electrophysiology
33%
Clinical Evaluation
33%
Acute Decompensated Heart Failure
33%
Base Rates
33%
Clinical High Risk
33%
Pacemaker Lead Extraction
33%
Laser Sheath
33%
InSync
33%
Randomized Clinical Trial
33%
CIED Infection
33%
Right Bundle Branch Block
33%
Tragic Choices
33%
Personalized Medicine
33%
Septal Region
33%
COVID-19 Pandemic
33%
Intra-atrial Reentrant Tachycardia
33%
Sinoatrial Node
33%
Adaptive Cardiac Resynchronization Therapy
33%
Adaptive CRT
33%
Radiofrequency Catheter Ablation
33%
Cardiovascular Care
33%
Novel Algorithm
33%
Staphylococcus Aureus Bacteremia
33%
CHADS2 Score
33%
CHA2DS2-VASc Score
33%
Permanent Pacemaker
33%
QRS Duration
33%
Ranolazine
33%
Bundle Branch Reentry
33%
Interfascicular Reentry
33%
Pacing Lead Extraction
33%
Medicine and Dentistry
Device Infection
100%
Atrial Fibrillation
100%
Cardiac Resynchronization Therapy
88%
Tachyarrhythmia
75%
End Stage Renal Disease
70%
Ventricular Tachycardia
66%
Coronary Sinus
66%
Catheter Ablation
66%
Implantable Automatic Defibrillator
66%
Hemodialysis
65%
Base
50%
Lead Extraction
47%
Apoplexy
47%
Left Ventricular Leads
42%
Infection
41%
Heart Atrium Pacing
41%
Heart Failure
41%
Peritoneal Dialysis
37%
Defibrillator
35%
Bundle Branches
35%
Ventricular Fibrillation
33%
Randomized Clinical Trial
33%
Staphylococcal Bacteremia
33%
Right Bundle Branch Block
33%
Permanent Pacemaker
33%
Cardiovascular System
33%
Left Ventricular Pacing
33%
Clinical Trial
33%
Risk Stratification
33%
Sinoatrial Node
33%
COVID-19
33%
Reentry Tachycardia
33%
Ranolazine
33%
QRS Interval
26%
CHA2DS2-VASc Score
25%
Awareness
25%
Atrial Flutter
23%
Odds Ratio
21%
Cardiac Dysrhythmia
20%
Bleeding
19%
Left Ventricle
19%
Major Bleeding
19%
CHADS2 Score
18%
Quality of Life
16%
Papillary Muscle
16%
Idiopathic Ventricular Tachycardia
16%
Endocardial Mapping
16%
Placebo
16%
Clinical Syndrome
16%
Palpitations
16%